July 16, 2015 | Red Hill Biopharma is set to issue another flotation on the NASDAQ stock exchange based on a shelf prospectus. Red Hill hopes to raise tens of millions of dollars in its offering. The flotation was underwritten by Nomura, Roth Capital Partners, MLV & Co., and HC Wainwright & Co. Red Hill Biopharma was founded in 2009 and develops drugs for the treatment of stomach ulcers, among other conditions.
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts

Israeli Startups Create Powerful Drone-Detecting Software
September 28, 2023

Model Sees Daylight As Boost For Hospitalized Patients’ Health
September 28, 2023

Solar Panels On A Roll Certified As Safe For Use In US, Europe
September 28, 2023

US Soldiers, Vets To Get Israeli-Made Helmets To Treat Depression
September 27, 2023
Facebook comments